miR‐7977 might be a relevant candidate since it can be transferred from different subtypes of AML cells to BMSC (Horiguchi et al, 2016) and syntenin is one of its main targets (Yoshida et al, 2019). The gene discussed is SDCBP; the disease is acute myeloid leukemia.